September 11, 2024 — In every way we look at this study, it is a remarkable milestone. With a randomized, controlled trial, Claudia Fox and colleagues have shown that a GLP-1, liraglutide, is effective for obesity in children as young as six years of age. In this year-long study, children who received liraglutide for obesity reduced their body mass […]
August 20, 2024 — Semaglutide – under the banner of Ozempic – has set a revolution of obesity medicines in motion. Suddenly, all of the huffing and puffing about “treating obesity seriously” and “obesity as a disease” is moot. Facts on the ground are persuading people to re-orient their thinking about obesity faster than essays and advocacy campaigns ever […]
July 21, 2023 — The President of Stanford University, Marc Tessier-Lavigne, announced his resignation this week, following a review of his research that concluded some of it “fell below customary standards of scientific rigor and process.” If you entertain any doubt about the importance of attention to scientific rigor and integrity, this should resolve it. Retractions and Corrections After […]
